INTRODUCTION: Laparoscopic surgeons in Great Britain and Ireland were surveyed to assess their use of antibiotic prophylaxis in elective laparoscopic cholecystectomy. This followed a Cochrane review that found no evidence to support the use of antibiotic prophylaxis in routine cases. METHODS: Data were collected on routine use of antibiotics in elective laparoscopic cholecystectomy, and how that was influenced by factors such as bile spillage, patient co-morbidities and surgeons' experience. An online questionnaire was sent to 450 laparoscopic surgeons in December 2011. RESULTS: Data were received from 111 surgeons (87 consultants) representing over 7,000 cases per year. In routine cases without bile spillage, 64% of respondents gave no antibiotics and 36% gave a single dose. In cases with bile spillage, 11% gave no antibiotics. However, 80% gave one dose and 7% gave three doses. Co-amoxiclav was used by 75% of surgeons. Surgeons are more likely to give antibiotics when patients have risk factors for infective endocarditis. CONCLUSIONS: This study suggests over 20,000 doses of antibiotics and over £100,000 could be saved annually if surgeons modified their practice to follow current guidelines.
INTRODUCTION: Laparoscopic surgeons in Great Britain and Ireland were surveyed to assess their use of antibiotic prophylaxis in elective laparoscopic cholecystectomy. This followed a Cochrane review that found no evidence to support the use of antibiotic prophylaxis in routine cases. METHODS: Data were collected on routine use of antibiotics in elective laparoscopic cholecystectomy, and how that was influenced by factors such as bile spillage, patient co-morbidities and surgeons' experience. An online questionnaire was sent to 450 laparoscopic surgeons in December 2011. RESULTS: Data were received from 111 surgeons (87 consultants) representing over 7,000 cases per year. In routine cases without bile spillage, 64% of respondents gave no antibiotics and 36% gave a single dose. In cases with bile spillage, 11% gave no antibiotics. However, 80% gave one dose and 7% gave three doses. Co-amoxiclav was used by 75% of surgeons. Surgeons are more likely to give antibiotics when patients have risk factors for infective endocarditis. CONCLUSIONS: This study suggests over 20,000 doses of antibiotics and over £100,000 could be saved annually if surgeons modified their practice to follow current guidelines.
Authors: Arthur R H van Zanten; Peter M Engelfriet; Karin van Dillen; Miriam van Veen; Mark J C Nuijten; Kees H Polderman Journal: Crit Care Date: 2003-10-14 Impact factor: 9.097
Authors: Margot E Cohen; Hojjat Salmasian; Jianhua Li; Jianfang Liu; Philip Zachariah; Jason D Wright; Daniel E Freedberg Journal: J Am Coll Surg Date: 2017-10-10 Impact factor: 6.113
Authors: Mahyar Mohammadifard; Ghodratollah Naseh; Rozita Khatamian Oskooi; Gholamreza Sharifzadeh; Samira Eshraghi Journal: J Family Med Prim Care Date: 2019-05
Authors: Bradley D Menz; Esmita Charani; David L Gordon; Andrew J M Leather; S Ramani Moonesinghe; Cameron J Phillips Journal: Infect Drug Resist Date: 2021-12-07 Impact factor: 4.003